Repetitive Phrenic Nerve Stimulation in Critically Ill Patients Under Mechanical Ventilation

NCT ID: NCT06491511

Last Updated: 2025-05-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

5 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-06-17

Study Completion Date

2024-09-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Subjects: Patients aged 19 and older who are currently in the ICU and undergoing invasive mechanical ventilation.

Methods: The study involves performing non-invasive repetitive phrenic nerve stimulation in ICU patients on mechanical ventilation.

Stimulation protocol: The intensity and position of phrenic nerve stimulation were individualized. The frequency was set to 10Hz, 15Hz, and 20Hz. The duration of stimulation was adjusted according to the set inspiration time of mechanical ventilation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Phrenic Nerve Electrical Stimulation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ICU patients

ICU patient with mechanical ventilator

Transcutaneous, repetitive phrenic nerve electrical stimulation

Intervention Type PROCEDURE

Phrenic nerve electrical stimulation with different stimulation intensity and frequency

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transcutaneous, repetitive phrenic nerve electrical stimulation

Phrenic nerve electrical stimulation with different stimulation intensity and frequency

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients aged 19 and older who are admitted to the ICU at Seoul National University Hospital
* Patients receiving invasive mechanical ventilation (via endotracheal tube or tracheostomy)
* Patients who have been on invasive mechanical ventilation (via endotracheal tube or tracheostomy) for more than 48 hours
* Patients who have listened to and understood the explanation of the purpose and procedures of the study and have voluntarily agreed to participate. In cases where the patient has impaired consciousness or cognitive function and is unable to consent, the patient's legal representative has agreed to the patient's participation in the study.

Exclusion Criteria

* Patients with implanted or externally applied electrical devices (such as pacemakers, defibrillators, implantable defibrillators, vagus nerve stimulators, spinal cord stimulators, gastric stimulators, diaphragm stimulators, etc.)
* Patients with a history of neck tumors, cervical spine instability, or neck surgery
* Patients with internal jugular vein catheters, infections, or inflammatory signs at the electrical stimulation site, making percutaneous phrenic nerve access impossible
* Patients with neurological or neuromuscular diseases that significantly affect respiratory muscle function
* Patients currently receiving neuromuscular blocking agents
* Patients already diagnosed with or suspected of having phrenic nerve paralysis
* Patients with elevated hemidiaphragm observed on chest X-ray
* Patients with pleural effusion occupying more than one-third of the pleural space or pneumothorax requiring chest tube insertion, as seen on chest X-ray
* Patients who are confirmed or presumed to be pregnant
* Patients with a body mass index (BMI) ≥ 40
* Patients for whom life-sustaining treatment has been decided to be withdrawn and who have no plans for active treatment
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Research Foundation of Korea

OTHER

Sponsor Role collaborator

Seoul National University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sung Eun Hyun

Assistant professor (MD, PhD)

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sung Eun Hyun, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Seoul National University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Seoul National University Hospital

Seoul, Seoul, South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2312-166-1498

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Learning and Ear Stimulation
NCT04812015 COMPLETED NA
Noninvasive Modulation of Chronic Neuropathic Pain
NCT06249724 WITHDRAWN PHASE1/PHASE2